Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

HTGMQ Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 15, 2023

Report Source: 2023 1st Quarter Report

Analyst's Ratings for HTG Molecular Diagnostics Inc (HTGMQ)

Based on 9 analysts giving stock ratings to HTG Molecular Diagnostics Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
33
Buy
56
Hold
11
Sell
0
Strong Sell
0
HTG Molecular Diagnostics Inc

HTG Molecular Diagnostics Inc. Stock Analysis HTGMQ

United States Health Care Nano Cap Report:
HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm's Gene Expression Panels include HTG Research Use Only (RUO) Panels and HTG EdgeSeq Research Use Only (RUO) Panels, such as the HTG Transcriptome Panel, HTG EdgeSeq miRNA Whole Transcriptome Assay, HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq Precision Immuno-Oncology Panel, HTG EdgeSeq Immune Response Panel, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq DLBCL Cell of Origin Assay. The HTG EdgeSeq system provides gene expression profiling for researchers, laboratory staff, and biomarker leads in discovery, translational medicine, and oncology applications. VERI/O Laboratory Services is a molecular lab providing gene expression profiling results.
Read More

HTG Molecular Diagnostics Inc (HTGMQ) Chart

Key Statistics of HTG Molecular Diagnostics Inc (HTGMQ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

100.00

P/E Ratio (TTM)

-

52 Week Range

$0$0.00

Market Cap

221.40

Avg. Volume

642.20

Dividend Yield

-

Financial Metrics & Statements of HTG Molecular Diagnostics Inc (HTGMQ)

FAQ's for HTG Molecular Diagnostics Inc (HTGMQ)

  • According to Musaffa’s Shariah screening methodology, HTG Molecular Diagnostics Inc (HTGMQ) is currently classified as NOT HALAL as of July 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HTG Molecular Diagnostics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in HTG Molecular Diagnostics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of HTG Molecular Diagnostics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of HTG Molecular Diagnostics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of HTG Molecular Diagnostics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.